{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T21:32:03Z","timestamp":1781818323853,"version":"3.54.5"},"reference-count":22,"publisher":"Scientific Scholar","content-domain":{"domain":["ijmr.org.in"],"crossmark-restriction":true},"short-container-title":["Indian J Med Res"],"abstract":"\n Background & objectives<\/jats:title>\n Gender-affirming hormone therapy may alter body composition and muscle strength, which may impact participation in sports and other activities. These changes are important to decide whether transgender should have separate categories of competition.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n We conducted this prospective study, to assess the body composition using bioelectrical impedance analysis muscle strength and serum irisin levels at baseline and at 12 months following gender affirming hormone therapy in transgender individuals. The comparisons were done in both cis mode and trans mode.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n A total of 32 transfemales and 22 transmales were included in the study. Among transwomen, there was an increase in total subcutaneous fat (9.2%) and visceral fat (11.3 %) (\n \n P<\/jats:italic>\n <\/jats:bold>\n <<\/jats:italic>\n 0.001 in both cis and trans mode comparison) and a decrease in muscle mass (7.7%) (\n \n P<\/jats:italic>\n <\/jats:bold>\n =<\/jats:italic>\n 0.033 and\n \n P<\/jats:italic>\n <\/jats:bold>\n <<\/jats:italic>\n 0.001 in cis and trans mode, respectively) and muscle strength at all sites (\n \n P<\/jats:italic>\n <\/jats:bold>\n <<\/jats:italic>\n 0.001). Among transmen, there was a decrease in total subcutaneous fat (5.9%) (\n \n P<\/jats:italic>\n <\/jats:bold>\n <<\/jats:italic>\n 0.001 for both cis and trans mode comparison) and an increase in muscle mass (7.2 %) (\n \n P<\/jats:italic>\n <\/jats:bold>\n <<\/jats:italic>\n 0.001 for trans mode only) and muscle strength except shoulder abduction on right side (\n \n P<\/jats:italic>\n <\/jats:bold>\n <<\/jats:italic>\n 0.001). No significant changes were observed in irisin levels following hormonal therapy.\n <\/jats:p>\n <\/jats:sec>\n \n Interpretation & conclusions<\/jats:title>\n Gender affirming hormonal therapy leads to body fat redistribution after twelve months of hormone therapy with significant alterations in muscle mass and strength among both transmen and transwomen. Irisin, an adipomyokine produced through muscle contraction, did not correlate with muscle mass or fat mass on follow up.<\/jats:p>\n <\/jats:sec>","DOI":"10.25259\/ijmr_560_2025","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T17:40:30Z","timestamp":1765215630000},"page":"513-519","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Body composition following gender\u00a0affirming hormone therapy in transgender individuals"],"prefix":"10.25259","volume":"162","author":[{"given":"Bharathi","family":"Kolla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramila","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"key":"10.25259\/IJMR_560_2025\/ref-1","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1007\/s00431-020-03906-y","article-title":"Gender incongruence and gender dysphoria in childhood and adolescence-current insights in diagnostics, management, and follow-up","volume":"180","author":"Claahsen-van der Grinten","year":"2021","journal-title":"Eur J Pediatr"},{"key":"10.25259\/IJMR_560_2025\/ref-2","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1590\/1516-4446-2016-2224","article-title":"Gender incongruence: a comparative study using ICD-10 and DSM-5 diagnostic criteria","volume":"40","author":"Soll","year":"2017","journal-title":"Braz J Psychiatry"},{"key":"10.25259\/IJMR_560_2025\/ref-3","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1210\/jc.2017-01658","article-title":"Endocrine treatment of gender-dysphoric\/gender-incongruent persons: An endocrine society clinical practice guideline","volume":"102","author":"Hembree","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.25259\/IJMR_560_2025\/ref-4","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jsxm.2017.12.009","article-title":"Early hormonal treatment affects body composition and body shape in young transgender adolescents","volume":"15","author":"Klaver","year":"2018","journal-title":"J Sex Med"},{"key":"10.25259\/IJMR_560_2025\/ref-5","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1530\/EJE-17-0496","article-title":"Changes in regional body fat, lean body mass and body shape in trans persons using cross-sex hormonal therapy: Results from a multicenter prospective study","volume":"178","author":"Klaver","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.25259\/IJMR_560_2025\/ref-6","doi-asserted-by":"publisher","first-page":"e1593","DOI":"10.1210\/clinem\/dgad750","article-title":"Time course of body composition changes in transgender adolescents during puberty suppression and sex hormone treatment","volume":"109","author":"Boogers","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.25259\/IJMR_560_2025\/ref-7","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1111\/jhn.13027","article-title":"Characterising body composition and bone health in transgender individuals receiving gender-affirming hormone therapy","volume":"35","author":"Ford","year":"2022","journal-title":"J Hum Nutr Diet"},{"key":"10.25259\/IJMR_560_2025\/ref-9","doi-asserted-by":"publisher","first-page":"20420188221099346","DOI":"10.1177\/20420188221099346","article-title":"Bone health in transgender people: a narrative review","volume":"13","author":"Giacomelli","year":"2022","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.25259\/IJMR_560_2025\/ref-10","doi-asserted-by":"publisher","first-page":"E270","DOI":"10.1210\/jc.2014-2439","article-title":"Bone mass in young adulthood following gonadotropin-releasing hormone analog treatment and cross-sex hormone treatment in adolescents with gender dysphoria","volume":"100","author":"Klink","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.25259\/IJMR_560_2025\/ref-11","doi-asserted-by":"publisher","first-page":"620608","DOI":"10.3389\/fphys.2021.620608","article-title":"Irisin: Anew code uncover the relationship of skeletal muscle and cardiovascular health during exercise","volume":"12","author":"Ma","year":"2021","journal-title":"Front Physiol"},{"key":"10.25259\/IJMR_560_2025\/ref-12","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3389\/fendo.2019.00621","article-title":"Association of irisin serum concentration and muscle strength in normal-weight and overweight young women","volume":"10","author":"Mart\u00ednez Mu\u00f1ozI","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.25259\/IJMR_560_2025\/ref-13","doi-asserted-by":"publisher","first-page":"3548284","DOI":"10.1155\/2019\/3548284","article-title":"Assessment of body composition in health and disease using bioelectrical impedance analysis (BIA) and dual energy X-Ray absorptiometry (DXA): a critical overview","volume":"2019","author":"Marra","year":"2019","journal-title":"Contrast Media Mol Imaging"},{"key":"10.25259\/IJMR_560_2025\/ref-14","doi-asserted-by":"publisher","first-page":"e0200465","DOI":"10.1371\/journal.pone.0200465","article-title":"Comparison of body composition assessment by DXA and BIA according to the body mass index: A retrospective study on 3655 measures","volume":"13","author":"Achamrah","year":"2018","journal-title":"PLoS One"},{"key":"10.25259\/IJMR_560_2025\/ref-15","first-page":"A788","article-title":"Body composition of transgender women after long-term hormone therapy\u2014Across-sectional study","volume":"5","author":"Alvares","year":"2021","journal-title":"J\u00a0Endocr Soc"},{"key":"10.25259\/IJMR_560_2025\/ref-16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.11005\/jbm.2021.28.1.59","article-title":"Effect of cross-sex hormones on body composition, bone mineral density, and muscle strength in trans women","volume":"28","author":"Yun","year":"2021","journal-title":"J Bone Metab"},{"key":"10.25259\/IJMR_560_2025\/ref-17","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1210\/js.2018-00413","article-title":"Bone mass effects of cross-sex hormone therapy in transgender people: Updated systematic review and meta-analysis","volume":"3","author":"Fighera","year":"2019","journal-title":"J\u00a0Endocr Soc"},{"key":"10.25259\/IJMR_560_2025\/ref-18","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1530\/EJE-14-0586","article-title":"Body composition, bone turnover, and bone mass in trans men during testosterone treatment: 1-year follow-up data from a prospective case-controlled study (ENIGI)","volume":"172","author":"Van Caenegem","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.25259\/IJMR_560_2025\/ref-19","doi-asserted-by":"publisher","first-page":"E596","DOI":"10.1210\/jc.2014-2934","article-title":"Association between sex hormones and adiposity: Qualitative differences in women and men in the multi-ethnic study of atherosclerosis","volume":"100","author":"Mongraw-Chaffin","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.25259\/IJMR_560_2025\/ref-20","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1210\/clinem\/dgab616","article-title":"Change in visceral fat and total body fat and the effect on cardiometabolic risk factors during transgender hormone therapy","volume":"107","author":"Klaver","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.25259\/IJMR_560_2025\/ref-21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0140-6736(03)15269-5","article-title":"The y-Y paradox","volume":"363","author":"Yajnik","year":"2004","journal-title":"Lancet"},{"key":"10.25259\/IJMR_560_2025\/ref-22","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1530\/EC-19-0196","article-title":"Change in grip strength in trans people and its association with lean body mass and bone density","volume":"8","author":"Scharff","year":"2019","journal-title":"Endocr Connect"},{"key":"10.25259\/IJMR_560_2025\/ref-23","doi-asserted-by":"publisher","first-page":"dgz247","DOI":"10.1210\/clinem\/dgz247","article-title":"Muscle strength, size, and composition following 12 months of gender-affirming treatment in transgender individuals","volume":"105","author":"Wiik","year":"2020","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ijmr.org.in\/body-composition-following-genderaffirming-hormone-therapy-in-transgender-individuals\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/ijmr.org.in\/body-composition-following-genderaffirming-hormone-therapy-in-transgender-individuals\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T17:40:30Z","timestamp":1765215630000},"score":1,"resource":{"primary":{"URL":"http:\/\/ijmr.org.in\/body-composition-following-genderaffirming-hormone-therapy-in-transgender-individuals\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":22,"alternative-id":["10.25259\/IJMR_560_2025"],"URL":"https:\/\/doi.org\/10.25259\/ijmr_560_2025","relation":{},"ISSN":["0971-5916"],"issn-type":[{"value":"0971-5916","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,8]]},"article-number":"513"}}